FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

JA Lavigne

Research Profile

Chemicals & Drugs

Procedures

Disorders

Breast Neoplasms

Physiology

Concepts & Ideas

Risk Factors

Anatomy

Tumor Cells, Cultured

Organizations

Blood Banks

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
JA Lavigne; Julie E Goodman; TEKUM FONONG; Shelly Odwin; Ping He; D W Roberts; James D Yager
The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Julie E Goodman; JA Lavigne; K Wu; Kathy J Helzlsouer; Paul T Strickland; J Selhub; James D Yager
COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk.
Julie E Goodman; JA Lavigne; Jan G Hengstler; B Tanner; Kathy J Helzlsouer; James D Yager
Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of JA Lavigne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2001: JA Lavigne; Julie E Goodman; TEKUM FONONG; Shelly Odwin; Ping He; D W Roberts; James D Yager
The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Cancer research 2001;61(20):7488-94.
2001: Julie E Goodman; JA Lavigne; K Wu; Kathy J Helzlsouer; Paul T Strickland; J Selhub; James D Yager
COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk.
Carcinogenesis 2001;22(10):1661-5.
2000: Julie E Goodman; JA Lavigne; Jan G Hengstler; B Tanner; Kathy J Helzlsouer; James D Yager
Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(12):1373-6.
1999: Jinqiang Chen; Yu Li; JA Lavigne; Michael A Trush; James D Yager
Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment.
Toxicological sciences : an official journal of the Society of Toxicology 1999;51(2):224-35.
1999: Kathy J Helzlsouer; Anthony J Alberg; Han-Yao Huang; Sandra C Hoffman; Paul T Strickland; J W Brock; V W Burse; L L Needham; Douglas A Bell; JA Lavigne; James D Yager; George W Comstock
Serum concentrations of organochlorine compounds and the subsequent development of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(6):525-32.
1997: JA Lavigne; Kathy J Helzlsouer; Han-Yao Huang; Paul T Strickland; Douglas A Bell; O Selmin; M A Watson; S Hoffman; George W Comstock; James D Yager
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Cancer research 1997;57(24):5493-7.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.